Multaq side effects leads to lawsuits
According to the U.S. Food & Drug Administration, Multaq (dronedarone) has been associated with liver damage and severe liver failure. The agency announced in 2011 an addition to the black box label for Multaq to warn patients of risk of severe complications and death. Doctors use Multaq to treat patients who have had an abnormal heart rhythm during the past six months. The FDA does not recommend Multaq for patients with recent severe heart failure or those referred to specialized heart failure clinics for the condition. Atrial fibrillation results from abnormal electrical activity in the upper chambers of the heart, leading to an irregular heart rhythm. According to the National Heart, Lung and Blood Institute, an estimated 2 million people in the U.S. suffer from atrial fibrillation, or a rapid and irregular heart beating.
You or a loved one may have suffered liver damage, severe liver failure or other adverse effects while taking Multaq. Contact Greg Jones Law as you may be entitled to compensation for medical bills, lost wages and pain and suffering.